IMATINIB (LUPINIB) TABLET – TREATMENT FOR MULTIPLE CANCER
Tyrosine kinase inhibitors are a family of drugs that includes lupinib 400 Tablet. It is used to treat gastrointestinal stromal tumors as well as two types of blood cancer: chronic myeloid leukemia and acute lymphocytic leukemia.
To achieve the best benefit, lupinib 400 mg tablet should be taken with food at the same time each day. As long as your doctor recommends it, you should keep taking it. Depending on your needs and how you respond to treatment, the length of treatment varies.
USES OF IMATINIB (LUPINIB) TABLET
- Blood cancer (Chronic myeloid leukemia)
- Blood cancer (Acute lymphocytic leukemia)
- Gastrointestinal stromal tumor
WORKS OF IMATINIB (LUPINIB) TABLET
Lupinib 400 Tablet is a cancer prevention drug. Bcr-Abl tyrosine kinase is a protein enzyme that is in charge of the aberrant proliferation of cancer cells. In bar-all positive cells, this medication suppresses proliferation and causes apoptosis (planned cell death) (cancer cells). This is how the progression of cancer is slowed or stopped.
SIDE EFFECTS OF IMATINIB (LUPINIB) TABLET
- Edema (swelling)
- Muscle cramp
- Musculoskeletal (bone, muscle, or joint) pain
- Abdominal pain
WARNING & PRECAUTIONS
The negative effects of lupinib 400 mg tablet may impair your ability to drive.
Patients with kidney problems should use lupinib 400 Tablets with caution. Lupinib 400 Tablet may require dose adjustment. Please speak with your physician.
When prescribed to patients with severe liver disease, lupinib 400 Tablet should be used with caution. Lupinib 400 Tablet may require dose adjustment. Please speak with your physician.
Fedelty Health Care is an Imatinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.